Browsing Tag

Cellectar Biosciences

Cellectar Biosciences Announces Closing of Concurrent Registered Direct and Private…

Eli Pacheco Oct 26, 2022 0

FLORHAM PARK, N.J., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and…

Health

Cellectar Announces Stock Consolidation

Eli Pacheco Jul 22, 2022 0

FLORHAM PARK, N.J., July 21, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage biopharmaceutical company focused on the discovery, development and…

Health

Cellectar Biosciences Announces Poster Presentation at the 63rd American Society for…

Eli Pacheco Dec 9, 2021 0

FLORHAM PARK, N.J., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and…

Health

Cellectar Announces Innovative Concierge Service for Patients Participating in Its…

Eli Pacheco Oct 25, 2021 0

FLORHAM PARK, N.J., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development…